REBECCA GREEN: Open Payments
NPI 1285086520 · LONDON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$259 in 14 payments from 8 companies in 2025. Trend: 2023 $65 · 2024 $178 · 2025 $259
Food & beverage: $259
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $110 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $32 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| Indivior Inc. | 1 | $23 |
| Lundbeck LLC | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
Products named: Ozempic, Rybelsus, CAPLYTA, HETLIOZ, SPRAVATO, SUBLOCADE, VYEPTI, Enhertu.
Industry payments across KY — which companies pay providers there.
